For patients undergoing PCI, the choice of antiplatelet therapy can be critical to post-treatment success, and to minimize the chance of heart attack or stroke.
A blood test to diagnose and classify tumors could be revolutionary and practice-changing for patients and clinicians alike
We’ve updated our Privacy Policy to make it clearer how we use your personal data. Please read our Cookie Policy to learn how we use cookies to provide you with a better experience.